Results 91 to 100 of about 1,809,346 (164)

Advances and challenges in poliomyelitis vaccines: a comprehensive review of development, production, and global deployment

open access: yesFrontiers in Public Health
Poliomyelitis has been a significant global health challenge for centuries. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, remarkable progress has been achieved, with wild poliovirus (WPV) cases reduced by over 99%.
Jia Liang, Qi Zhang, Yanan Li, Lili Wang
doaj   +1 more source

Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination

open access: yes
Introduction: Prior research explores whether seasonal and childhood vaccines mitigate the risk of SARS-CoV-2 infection. Although there are trials investigating COVID-19 infection in response to the effects of the oral poliovirus vaccine (OPV), there has
Chisom Azodoh   +6 more
core   +1 more source

Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak

open access: yes, 2017
<p>Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: a retrospective study</p ...
Sabine Diedrich (4870441)   +23 more
core   +1 more source

Growth kinetic analysis of bi-recombinant poliovirus vaccine strains

open access: yes, 2010
Attenuated strains of Sabin poliovirus vaccine replicate in the human gut and in rare cases may cause vaccine-associated paralytic poliomyelitis (VAPP).
Papadi, G.   +15 more
core   +1 more source

Evolution of a rare vaccine-derived multirecombinant poliovirus

open access: yes, 2005
Recombination is one of the mechanisms by which viral genomes evolve. A vaccine-derived multirecombinant poliovirus strain was isolated from a 5-month-old child with vaccine-associated paralytic poliomyelitis after oral poliovirus vaccine administration.
Markoulatos, P.   +2 more
core   +1 more source

Impediments to Progress Toward Polio Eradication During 2014–2024: Effectively Addressing the Current Challenges

open access: yesVaccines
When the Global Polio Eradication Initiative (GPEI) began in 1988, the year 2000 target was clearly ambitious. Nonetheless, among 20 countries with endemic wild poliovirus transmission in 2000, only Afghanistan, Nigeria and Pakistan remained endemic in ...
Steven G. F. Wassilak   +2 more
doaj   +1 more source

Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency

open access: yesPathogens
A sharp rise in circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreaks in the years following the cessation of routine use of poliovirus type 2-containing oral polio vaccine and the trend of seeding new emergences with suboptimal vaccination ...
Feyrouz Damji Kurji   +9 more
doaj   +1 more source

Emerg Infect Dis

open access: yes
Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine.

core  

National inventory for poliovirus containment : minimizing risk of poliovirus release from laboratories in the United States [PDF]

open access: yes
The US Poliovirus National Authority for Containment of Poliovirus (NAC), located in the Centers for Disease Control and Prevention, Center for Preparedness and Response, appreciates your participation in this survey.

core  

Immune persistence after different polio sequential immunization schedules in Chinese infants

open access: yesnpj Vaccines
Trivalent oral poliovirus vaccine (tOPV) has been withdrawn and instead an inactivated poliovirus vaccine (IPV) and bivalent type 1 and type 3 OPV (bOPV) sequential immunization schedule has been implemented since 2016, but no immune persistence data are
Ting Zhao   +33 more
doaj   +1 more source

Home - About - Disclaimer - Privacy